adolescents | CARLAT PUBLISHING

EXPERT Q&A

Dialectical Behavior Therapy for Adolescents

July 22, 2024

Alec L. Miller, PsyD. Co-Founder and Co-Director, Cognitive & Behavioral Consultants of Westchester, LLP, White Plains, NY; President, Access Psychology Foundation; Clinical Professor of Psychiatry and Behavioral Sciences Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY. He is also co-author of three textbooks published by Guilford Press applying dialectical behavioral therapy to adolescents in clinical and school settings.

Dr. Miller discloses that he receives royalties from Guilford Press and PsychWire. This educational activity has been reviewed and it has been determined that there is no commercial bias as a result of this financial relationship.

This interview features the co-developer of a multimodal treatment that adapted DBT for suicidal adolescents. This innovative approach filled a critical gap where no other effective treatments existed.

Clinical Update

Managing a Dilemma: Social Contagion Self-Diagnosis in Adolescents and Young Adults

July 1, 2024

Circe Cooke, MD

Circe Cooke, MD. Child and adolescent psychiatrist, Presbyterian Healthcare Services, Albuquerque, NM.

Dr. Cooke has no financial relationships with companies related to this material.

Can kids and teens "catch" mental illness from the internet? This clinical update covers how to assess the degree of media influence on symptoms that children and adolescents report and how to talk with kids and teens about self-diagnoses in a way that builds a collaborative exploratory treatment relationship.

Research Update

OCD Treatment From Home

July 1, 2024

Mariel Zeccola, APRN, PhD

Mariel Zeccola, APRN, PhD. Dr. Zeccola has no financial relationships with companies related to this material.

Online treatment offers greater access to care for our patients with reduced travel and environmental costs. But is this modality effective? This research update looks at a study in which internet-based cognitive behavioral therapy was used for treating OCD in children and teens.

Research Update

Alcohol Dependence in Teens Linked to Depression in Young Adults

July 1, 2024

Susan L. Siegfreid, MD

Susan Siegfreid, MD. Dr. Siegfreid has no financial relationships with companies related to this material.

What is the impact of alcohol use in teens on their risk for developing depression? Spoiler alert: If it were a clear linear relationship, there would be no story here. Read this research update and use it to improve your process for screening for alcohol use.

Research Update

Physical Activity for Depression in Youth: A Closer Look at the Data

July 1, 2024

Susan L. Siegfreid, MD

Susan Siegfreid, MD. Dr. Siegfreid has no financial relationships with companies related to this material.

Does physical activity help relieve depression in children and adolescents? We know it helps adults, but what is the evidence in kids? This research update looks at a study that tries to elucidate the effectiveness of exercise on depression in kids and teens, and how much to emphasize exercise with your own patients.

Clinical Update

Addressing Social Isolation and Loneliness in Children and Teens

July 1, 2024

Aydar Shaildayev, MD and Eric Whitney, MD

Aydar Shaildayev, MD. Psychiatry resident, NYU Langone, New York, NY.

Eric Whitney, MD. Clinical assistant professor, Department of Child and Adolescent Psychiatry, NYU Grossman School of Medicine, New York, NY.

Drs. Shaildayev and Whitney have no financial relationships with companies related to this material.

The Surgeon General has put out a call to address loneliness and social isolation. But what do we do about it? This clinical update will help you define loneliness and social isolation, assess for them, and help lonely or isolated kids and teens.

RESEARCH UPDATE

Lithium vs Quetiapine for Acute Mania in Youth

April 1, 2024

Earth Hasassri, MD

Earth Hasassri, MD. Dr. Hasassri has no financial relationships with companies related to this material.

How do lithium and quetiapine compare in their ability to treat acute mania in children and teens? Are they effective? Do kids go into remission? And how do their side effect profiles compare? This clinical update can help you decide which patients might be good candidates for which medication.

Expert Q&A

Tolerability of Vortioxetine for Pediatric Anxiety and Depressive Disorders

January 1, 2024

Kathryn Martin, MD, MPH

Kathryn Martin, MD, MPH. Dr. Martin discloses that she owns shares in a variety of pharmaceutical companies. Relevant financial relationships listed for the author have been mitigated.

Vortioxetine has to be reasonably tolerated in children and teens, with manageable side effects, to have any chance of inclusion into treatment for anxiety or depression. This research update gives you the latest on whether vortioxetine might be a viable approach even before we have good efficacy studies.

Research Update

Does Adding Topiramate to Aripiprazole for Mania Improve Metabolic Outcomes?

January 1, 2024

Dorothy Chyung, MD

Dorothy Chyung, MD. Dr. Chyung has no financial relationships related to this material.

We struggle to manage the metabolic impact of antipsychotic medications on the children and teens we treat. Could topiramate be a viable option for our armamentarium of strategies? Read our research update to find out.

Clinical Update

Lithium for Children and Adolescents

November 2, 2023

Max S. Rosen, MD

Max S. Rosen, MD. Assistant Professor of Psychiatry (Child); Director, Child & Adolescent Psychiatry Outpatient Services; Washington University School of Medicine, St. Louis, MO.

Dr. Rosen has no financial relationships with companies related to this material.

Lithium is FDA-approved for bipolar disorder in children and adolescents 12 years and up; however, its potential off-label utility is broad, from affective aggression to anorexia nervosa. This clinical update covers how to prescribe lithium for children and adolescents and how to talk with patients and parents about lithium.